Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
about
Implications of glial nitric oxide in neurodegenerative diseasesMagnetic resonance imaging markers for early diagnosis of Parkinson's diseaseAn in vivo animal study assessing long-term changes in hypothalamic cytokines following perinatal exposure to a chemical mixture based on Arctic maternal body burdenMethamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the ratMining relational paths in integrated biomedical dataProteomic analysis of the effects of aged garlic extract and its FruArg component on lipopolysaccharide-induced neuroinflammatory response in microglial cellsNitrated alpha-synuclein and microglial neuroregulatory activities.IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotectionMicroglia in the aging brain: relevance to neurodegenerationNovel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior.Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in RatsPeripheral nerve regeneration and NGF-dependent neurite outgrowth of adult sensory neurons converge on STAT3 phosphorylation downstream of neuropoietic cytokine receptor gp130.Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.Chunghyuldan attenuates brain microglial inflammatory response.The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons.Homeostatic interferon expression in neurons is sufficient for early control of viral infectionMelittin restores proteasome function in an animal model of ALSThe induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation.Regulatory effects of caffeic acid phenethyl ester on neuroinflammation in microglial cellsValproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Malaysian endophytic fungal extracts-induced anti-inflammation in Lipopolysaccharide-activated BV-2 microglia is associated with attenuation of NO production and, IL-6 and TNF-α expression.Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells.Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson diseaseUp-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation.Modulation of Lipopolysaccharide Stimulated Nuclear Factor kappa B Mediated iNOS/NO Production by Bromelain in Rat Primary Microglial Cells.Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices.RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesLinking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian PoisonsDistinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.Vaccinium bracteatum Thunb. Exerts Anti-Inflammatory Activity by Inhibiting NF-κB Activation in BV-2 Microglial Cells.Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson's diseasePlasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.Melittin ameliorates the inflammation of organs in an amyotrophic lateral sclerosis animal model.Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease.Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases.
P2860
Q26782894-BDAEBEA0-BE2A-4180-AB2B-F279D7EF3196Q26865688-A86FCCD8-58D1-4781-BAE4-3DC760E239DCQ28390825-35AC98AD-A9D5-458C-B398-D8C31F9ED130Q28472559-B401C33E-7292-43D1-ABAA-25491BB9F9BCQ28478280-4781A0A4-6801-4D0A-B3D2-A04C8A50FBE8Q28545139-908F9EAF-04AF-4C43-92E6-F1451BB5A2B9Q33315262-986470CB-BD6A-4922-9BA8-6136C70D09E8Q33665740-313AD6A6-982B-4B5F-88D9-1F2C4EC8FA6BQ33780335-36DE77EC-457B-4D62-A78C-32CFF222F4AFQ33851514-D461552B-C1F9-4F16-A1F6-2E5809C56839Q33905707-133348FC-FAAE-4249-B6EE-E79FA749A9FCQ34233497-BFAC6714-6D6E-440D-AE0C-5E201272C264Q34282683-4B02B90F-BA28-47CB-BAB5-7CA37AC4459FQ34983243-0A3D5D2B-16CC-426F-8EFA-E85759EB8FEEQ34986760-F384B6CE-E39C-4D1D-8678-F34D2BAA1E14Q35050577-C54E06A0-AAAB-4817-9A3F-73FF4058D639Q35075450-FB7B90AE-2AAA-4D9E-B4C3-C588E97F1708Q35123965-C21906F8-9DDD-48D4-AAE1-00D06A4BC90EQ35233197-1687E4D1-E6D2-4E55-8939-43D182049B50Q35381202-BCE73AF8-6758-4F73-8949-2F78A425DADBQ35623461-0C3A5C57-3427-41FE-B2BC-11C681F44029Q35654811-CB41393F-B55D-4A4B-823A-78E983D0997CQ35787969-FE413A7E-C955-4B0D-8E10-6696A5FC6F84Q35808114-2707A60B-CEBB-46A1-9D92-8DAF48BA3571Q35899904-BDB9C9BB-48CB-4A2A-B32C-3611202A77D6Q36136789-1C859374-097C-492C-B5A7-49D5F1226A4EQ36399086-F1D50A64-8F41-4E24-AFE2-8ADEB4793268Q36700366-2F4E925B-91BE-45BD-9C40-DE321B72CD6FQ36750245-C80AAB1C-B751-4386-8479-78478DFBAC12Q36773965-1991007F-5556-4C9F-8DF4-3828DC061227Q36830938-9EA98AAD-AAE9-4ABB-9390-7BF3B2FAEF8EQ36935441-62E16969-C05B-4742-A02D-96A6B0D6C626Q37076753-C94FF3E8-E04B-4567-8D0F-2D13BCEF7DB1Q37235280-588E3C06-7759-4597-88E0-99900D048BA9Q37333346-1DEF0A77-6D1E-4A70-A2A4-43EA8006F380Q37409148-4AA7CE43-1B06-4341-9367-ABC2ADCF166CQ37653212-09099B0A-7B65-4E80-B1AF-0F1EEDD822EBQ37700144-134E882F-59D8-4010-85C6-66C3B7F32B53Q37745148-498DB66F-6186-4DAB-A87E-E8CDB0D27780Q37798654-F7200327-B4F8-4878-8CBE-232382DD8228
P2860
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inflammation in Parkinson's di ...... and therapeutic implications.
@en
type
label
Inflammation in Parkinson's di ...... and therapeutic implications.
@en
prefLabel
Inflammation in Parkinson's di ...... and therapeutic implications.
@en
P2093
P1476
Inflammation in Parkinson's di ...... e and therapeutic implications
@en
P2093
P304
P356
10.2174/138161207780858429
P50
P577
2007-01-01T00:00:00Z